Description
BPC-157 – Research Peptide
BPC-157 is a synthetic pentadecapeptide characterized by a defined sequence of 15 amino acids. It has been investigated in preclinical and laboratory research, making it a frequently discussed peptide within the scientific literature.
LV Longevity Peptides presents BPC-157 as a research-use peptide for controlled laboratory investigation and analytical work. The product page provides relevant chemical information, product specifications and research context so researchers can evaluate the material according to their own experimental requirements.
BPC-157 has attracted considerable scientific interest, but it is important to distinguish preclinical research findings from established clinical applications. Recent literature continues to identify significant translational and development gaps, and BPC-157 does not have an FDA-approved therapeutic formulation.
BPC-157 Chemical Information
| Property | Information |
|---|---|
| Product Name | BPC-157 |
| Peptide Type | Synthetic pentadecapeptide |
| Molecular Formula | C₆₂H₉₈N₁₆O₂₂ |
| Approximate Molecular Weight | 1419.54 g/mol |
| Sequence | Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val |
The molecular formula, molecular weight and 15-amino-acid sequence correspond to the information published on the competitor’s current BPC-157 product page and are also consistent with descriptions in the scientific literature.
BPC-157 Research Context
BPC-157 has been investigated primarily through preclinical research models rather than established clinical applications.
Research literature has examined the peptide in relation to several biological systems and experimental models. However, findings from animal or laboratory studies should not be presented as evidence of established human therapeutic efficacy.
A recent 2026 review specifically highlighted the gap between extensive preclinical investigation and clinical development, noting the absence of an approved formulation and validated clinical dosing regimen.
This distinction is important when evaluating BPC-157 as a research material.
BPC-157 Research Applications
Depending on the experimental design, BPC-157 may be investigated in controlled laboratory environments for areas including:
- peptide characterization
- sequence and structural analysis
- stability investigations
- degradation studies
- biochemical research
- cell-based experimental models
- peptide interaction studies
- comparative peptide research
- analytical methodology development
These descriptions refer to research contexts, not medical indications or recommendations for human use.
BPC-157 Molecular Structure
BPC-157 is characterized as a pentadecapeptide containing 15 amino acids.
Its reported sequence is:
Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
For researchers working with peptide materials, documenting sequence and molecular identity is an important part of analytical characterization.
Where available, LV Longevity Peptides should provide relevant analytical documentation and batch-specific information alongside the product.
BPC-157 Product Specifications
| Specification | Product Information |
|---|---|
| Product | BPC-157 |
| Format | [LYOPHILIZED POWDER / OTHER ACTUAL FORMAT] |
| Quantity | [ACTUAL QUANTITY] |
| Appearance | [ACTUAL DESCRIPTION] |
| Molecular Weight | 1419.54 g/mol |
| Molecular Formula | C₆₂H₉₈N₁₆O₂₂ |
| Sequence | Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val |
Frequently Asked Questions
What is BPC-157?
BPC-157 is a synthetic pentadecapeptide characterized by a defined sequence of 15 amino acids. It has been investigated extensively in preclinical and laboratory research.
What is the amino acid sequence of BPC-157?
The commonly reported sequence is:
Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val.
What is the molecular weight of BPC-157?
BPC-157 has a reported molecular weight of approximately 1419.54 g/mol.
What is the molecular formula of BPC-157?
The reported molecular formula is:
C₆₂H₉₈N₁₆O₂₂.
What is BPC-157 studied for?
BPC-157 has been investigated in a range of preclinical research models. Laboratory research has examined its biological activity, peptide characteristics and interactions across different experimental systems. These findings should not be interpreted as established human therapeutic effects.
How should BPC-157 research material be evaluated?
Researchers should review the product’s specifications, identity information, applicable analytical documentation, batch information and intended experimental requirements before using a research material.
Reviews
There are no reviews yet.